Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle

Show other versions (2)

Vaccination is being considered as part of a sustainable strategy for the control of bovine tuberculosis (BTB) in the UK. The live attenuated Mycobacterium bovis bacillus Calmette-Guerin (BCG) has been used experimentally to vaccinate cattle against BTB. However, BCG confers partial protection again...

Full description

Bibliographic Details
Main Authors:	Villarreal-Ramos, B, Berg, S, Chamberlain, L, Mcshane, H, Hewinson, R, Clifford, D, Vordermeier, M
Format:	Journal article
Language:	English
Published:	Elsevier 2014

Similar Items

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.
by: Villarreal-Ramos, B, et al.
Published: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
by: Villarreal-Ramos, B, et al.
Published: (2017)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
by: Dean, G, et al.
Published: (2014)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
by: Vordermeier, H, et al.
Published: (2009)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
by: Dean, G, et al.
Published: (2014)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
by: Vordermeier, H, et al.
Published: (2011)

The humoral immune response to BCG vaccination
by: Tanner, R, et al.
Published: (2019)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
by: Vordermeier, H, et al.
Published: (2011)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
by: Minassian, A, et al.
Published: (2011)

Vaccination against tuberculosis: how can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Vaccination against tuberculosis: How can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
by: Dean, G, et al.
Published: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
by: Dean, G, et al.
Published: (2014)

A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression
by: Perez de Val, B, et al.
Published: (2013)

A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression
by: Pérez De Val, B, et al.
Published: (2013)

Clinical testing of tuberculosis vaccine candidates
by: Hatherill, M, et al.
Published: (2016)

Proteoliposomes from mycobacterium bovis BCG and mycobacterium smegmatis as new vaccine candidates against tuberculosis
by: Kadir, Ramlah
Published: (2016)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
by: Biffar, L, et al.
Published: (2019)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
by: Mcshane, H, et al.
Published: (2005)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
by: Harris, SA, et al.
Published: (2014)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
by: Harris, S, et al.
Published: (2017)

Vaccine strategies against tuberculosis.
by: Mcshane, H
Published: (2009)

Developing an improved vaccine against tuberculosis.
by: Mcshane, H
Published: (2004)

Experimental infection of cattle with Mycobacterium tuberculosis isolates shows the attenuation of the human tubercle bacillus for cattle
by: Villarreal-Ramos, B, et al.
Published: (2018)

Cloning of vacll into pnmn013: development of a recombinant bcg vaccine against tuberculosis
by: Ramli, Siti Nur Rasyidah Md
Published: (2004)

Insights and challenges in tuberculosis vaccine development
by: McShane, H
Published: (2019)

Tuberculosis vaccines: progress and challenges.
by: Checkley, A, et al.
Published: (2011)

Tuberculosis vaccines: Progress and challenges
by: Checkley, A, et al.
Published: (2011)

Development of a primate model for tuberculosis vaccine research: IFN-gamma responses induced by BCG vaccination and M-tuberculosis infection in macaques
by: Dowall, S, et al.
Published: (2007)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
by: Harris, S, et al.
Published: (2013)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
by: Williams, A, et al.
Published: (2005)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
by: Poyntz, H, et al.
Published: (2014)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
by: Rowland, R, et al.
Published: (2013)

Temporal dynamics of intradermal cytokine response to tuberculin in Mycobacterium bovis BCG-vaccinated cattle using sampling microneedles
by: Steinbach, Sabine, et al.
Published: (2022)

Temporal dynamics of intradermal cytokine response to tuberculin in Mycobacterium bovis BCG-vaccinated cattle using sampling microneedles
by: Steinbach, Sabine, et al.
Published: (2021)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
by: Poyntz, H, et al.
Published: (2014)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
by: Pathan, A, et al.
Published: (2012)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
by: Fletcher, H, et al.
Published: (2009)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
by: Minhinnick, A, et al.
Published: (2016)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
by: Pathan, A, et al.
Published: (2012)